Metabolic Syndrome Post-Liver Transplant: Can We Predict?

Abstract

Get full access to this article

View all access options for this article.

References

Paguex

et al. Long term outcomes of liver transplantation: Diabetes mellitus. Liver Transpl, 2009; 15 Suppl 2:S79–S82.

Morbitzer

et al. The impact of diabetes mellitus and glycemic control on clinical outcomes following liver transplant for hepatitis C. Clin Transplant, 2014; 28:862–868.

Shintani

et al. Hepatitis C virus infection and diabetes: Direct involvement of the virus in the development of insulin resistance. Gastroenterology, 2004; 126:840–848.

Banerjee

et al. Hepatitis C virus differentially modulates activation of forkhead transcription factors and insulin-induced metabolic gene expression. J Virol, 2010; 84:5936–5946.

Lunati

et al. Metabolic syndrome after liver transplantation: Short-term prevalence and pre- and post-operative risk factors. Dig Liver Dis, 2013; 45:833–839.

Fussner

et al. Cardiovascular disease after liver transplantation: When, what, and who is at risk. Liver Transpl, 2015; 21:889–896.

Laryea

et al. Metabolic syndrome in liver transplant recipients: Prevalence and association with major vascular events. Liver Transpl, 2007; 13:1109–1114.

Kahn

et al. Prospective analysis of metabolic parameters in the detection of diabetes and metabolic syndrome in liver transplant recipients. Metab Syndr Relat Disord, 2016; 14:305–310.